{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T22:25:53Z","timestamp":1744410353676,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00345-020-03566-5","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T09:04:54Z","timestamp":1613984694000},"page":"3309-3314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MRI predicts prostatic urethral involvement in men undergoing radical prostatectomy: implications for cryo-ablation of localized prostate cancer"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3353-7560","authenticated-orcid":false,"given":"Ezequiel","family":"Becher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Sali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Ming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chhavi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inderbir","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju","family":"Aron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Lepor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"issue":"4","key":"3566_CR1","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.juro.2018.01.002","volume":"199","author":"MG Sanda","year":"2018","unstructured":"Sanda MG, Cadeddu JA, Kirkby E et al (2018) Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part II: recommended approaches and details of specific care options. J Urol 199(4):990\u2013997","journal-title":"J Urol"},{"issue":"4","key":"3566_CR2","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/1097-0142(19930815)72:4<1291::AID-CNCR2820720423>3.0.CO;2-I","volume":"72","author":"GM Onik","year":"1993","unstructured":"Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J (1993) Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 72(4):1291\u20131299","journal-title":"Cancer"},{"issue":"2","key":"3566_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/cncr.24779","volume":"116","author":"BJ Donnelly","year":"2010","unstructured":"Donnelly BJ, Saliken JC, Brasher PM et al (2010) A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer 116(2):323\u2013330","journal-title":"Cancer"},{"key":"3566_CR4","first-page":"CD005010","volume":"3","author":"M Shelley","year":"2007","unstructured":"Shelley M, Wilt TJ, Coles B, Mason MD (2007) Cryotherapy for localised prostate cancer. Cochrane Database Syst Rev 3:CD005010","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"3566_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0090-4295(99)80095-8","volume":"45","author":"JK Cohen","year":"1995","unstructured":"Cohen JK, Miller RJ, Shuman BA (1995) Urethral warming catheter for use during cryoablation of the prostate. Urology 45(5):861\u2013864","journal-title":"Urology"},{"issue":"4","key":"3566_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/pcan.2013.32","volume":"16","author":"MM Padilha","year":"2013","unstructured":"Padilha MM, Stephen Jones J, Streator Smith K, Zhou M, Walker E, Magi-Galluzzi C (2013) Prediction of prostate cancer to urethra distance by a pretreatment nomogram: urethral thermoprotection implication in cryoablation. Prostate Cancer Prostatic Dis 16(4):372\u2013375","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"3566_CR7","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0090-4295(00)00792-5","volume":"56","author":"BC Leibovich","year":"2000","unstructured":"Leibovich BC, Blute ML, Bostwick DG et al (2000) Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. Urology 56(5):726\u2013729","journal-title":"Urology"},{"issue":"6","key":"3566_CR8","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.eururo.2015.01.013","volume":"68","author":"JJ Futterer","year":"2015","unstructured":"Futterer JJ, Briganti A, De Visschere P et al (2015) Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 68(6):1045\u20131053","journal-title":"Eur Urol"},{"issue":"6","key":"3566_CR9","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.urology.2015.07.038","volume":"86","author":"N Mendhiratta","year":"2015","unstructured":"Mendhiratta N, Meng X, Rosenkrantz AB et al (2015) Prebiopsy MRI and MRI-ultrasound fusion-targeted prostate biopsy in men with previous negative biopsies: impact on repeat biopsy strategies. Urology 86(6):1192\u20131198","journal-title":"Urology"},{"issue":"4","key":"3566_CR10","doi-asserted-by":"publisher","first-page":"772","DOI":"10.2214\/AJR.13.11187","volume":"202","author":"Y Chong","year":"2014","unstructured":"Chong Y, Kim CK, Park SY, Park BK, Kwon GY, Park JJ (2014) Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study. AJR Am J Roentgenol 202(4):772\u2013777","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"3566_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/bju.13987","volume":"121","author":"AP Kenigsberg","year":"2018","unstructured":"Kenigsberg AP, Tamada T, Rosenkrantz AB et al (2018) Multiparametric magnetic resonance imaging identifies significant apical prostate cancers. BJU international 121(2):239\u2013243","journal-title":"BJU international"},{"issue":"1","key":"3566_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/modpathol.2010.178","volume":"24","author":"H Samaratunga","year":"2011","unstructured":"Samaratunga H, Montironi R, True L et al (2011) International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 1: specimen handling. Mod Pathol 24(1):6\u201315","journal-title":"Mod Pathol"},{"issue":"5","key":"3566_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00428-014-1557-y","volume":"464","author":"CC Huang","year":"2014","unstructured":"Huang CC, Deng FM, Kong MX, Ren Q, Melamed J, Zhou M (2014) Re-evaluating the concept of \u201cdominant\/index tumor nodule\u201d in multifocal prostate cancer. Virchows Arch 464(5):589\u2013594","journal-title":"Virchows Arch"},{"issue":"1","key":"3566_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS prostate imaging-reporting and data system: 2015, version 2. Eur Urol 69(1):16\u201340","journal-title":"Eur Urol"},{"issue":"3","key":"3566_CR15","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.eururo.2012.05.046","volume":"62","author":"V Ficarra","year":"2012","unstructured":"Ficarra V, Novara G, Ahlering TE et al (2012) Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol 62(3):418\u2013430","journal-title":"Eur Urol"},{"issue":"3","key":"3566_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eururo.2012.05.045","volume":"62","author":"V Ficarra","year":"2012","unstructured":"Ficarra V, Novara G, Rosen RC et al (2012) Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 62(3):405\u2013417","journal-title":"Eur Urol"},{"issue":"3","key":"3566_CR17","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.eururo.2016.06.023","volume":"71","author":"SF Mungovan","year":"2017","unstructured":"Mungovan SF, Sandhu JS, Akin O, Smart NA, Graham PL, Patel MI (2017) Preoperative membranous urethral length measurement and continence recovery following radical prostatectomy: a systematic review and meta-analysis. Eur Urol 71(3):368\u2013378","journal-title":"Eur Urol"},{"issue":"2","key":"3566_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.urology.2015.06.003","volume":"86","author":"TS Feng","year":"2015","unstructured":"Feng TS, Sharif-Afshar AR, Wu J et al (2015) Multiparametric MRI improves accuracy of clinical nomograms for predicting extracapsular extension of prostate cancer. Urology 86(2):332\u2013337","journal-title":"Urology"},{"issue":"7","key":"3566_CR19","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s00345-019-02762-2","volume":"37","author":"J Marenco","year":"2019","unstructured":"Marenco J, Orczyk C, Collins T, Moore C, Emberton M (2019) Role of MRI in planning radical prostatectomy: what is the added value? World J Urol 37(7):1289\u20131292","journal-title":"World J Urol"},{"issue":"1","key":"3566_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cryobiol.2014.06.004","volume":"69","author":"C Favazza","year":"2014","unstructured":"Favazza C, Gorny K, King D et al (2014) An investigation of the effects from a urethral warming system on temperature distributions during cryoablation treatment of the prostate: a phantom study. Cryobiology 69(1):128\u2013133","journal-title":"Cryobiology"},{"issue":"2","key":"3566_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.eururo.2008.05.032","volume":"54","author":"ED Crawford","year":"2008","unstructured":"Crawford ED, Abrahamsson P-A (2008) PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 54(2):262\u2013273","journal-title":"Eur Urol"},{"issue":"4","key":"3566_CR22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ijrobp.2004.12.068","volume":"62","author":"ZA Allen","year":"2005","unstructured":"Allen ZA, Merrick GS, Butler WM et al (2005) Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity. Int J Radiat Oncol Biol Phys 62(4):981\u2013987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3566_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1748-717X-7-82","volume":"7","author":"J Vainshtein","year":"2012","unstructured":"Vainshtein J, Abu-Isa E, Olson KB et al (2012) Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. Radiat Oncol 7:82","journal-title":"Radiat Oncol"},{"key":"3566_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fonc.2016.00122","volume":"6","author":"MC Repka","year":"2016","unstructured":"Repka MC, Guleria S, Cyr RA et al (2016) Acute urinary morbidity following stereotactic body radiation therapy for prostate cancer with prophylactic alpha-adrenergic antagonist and urethral dose reduction. Front Oncol 6:122","journal-title":"Front Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03566-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-020-03566-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03566-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T01:40:14Z","timestamp":1634089214000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-020-03566-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["3566"],"URL":"https:\/\/doi.org\/10.1007\/s00345-020-03566-5","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"type":"print","value":"0724-4983"},{"type":"electronic","value":"1433-8726"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"assertion":[{"value":"28 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"AA: Consultant for Koelis and was proctor in training for Steba Biotech.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}